Defective T-cell activation caused by impairment of the TNF receptor 2 costimulatory pathway in common variable immunodeficiency

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 5, 2007, Pages 1193-1200

  Aspalter, Rosa M ^a   Eibl, Martha M ^a   Wolf, Hermann M ^a  

^a Immunology Outpatient Clinic   (Austria)

Author keywords

calcium flux; CVID; PKC ; primary immunodeficiency; store operated calcium channels; T cell receptor; TNF ; TNF RII; TRAF1

Indexed keywords

CALCIUM CHANNEL; CD28 ANTIGEN; CD69 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE C; RAS PROTEIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; CALCIUM TRANSPORT; CELL SEPARATION; CELL STIMULATION; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOSTIMULATION; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING;

ADULT; AGED; ANTIGENS, CD28; CALCIUM SIGNALING; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PROTEIN KINASE C; PROTEIN TRANSPORT; RAS PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; T-LYMPHOCYTES;

EID: 35648976633     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.07.004     Document Type: Article

References (42)

1. Notarangelo L., Casanova J.L., Conley M.E., Chapel H., Fischer A., Puck J., et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol 117 (2006) 883-896
2. Cunningham-Rundles C., Radigan L., Knight A.K., Zhang L., Bauer L., and Nakazawa A. TLR9 activation is defective in common variable immune deficiency. J Immunol 176 (2006) 1978-1987
3. Boncristiano M., Majolini M.B., D'Elios M.M., Pacini S., Valensin S., Ulivieri C., et al. Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects. Eur J Immunol 30 (2000) 2632-2638
4. Paccani S.R., Patrussi L., Ulivieri C., Masferrer J.L., D'Elios M.M., and Baldari C.T. Nonsteroidal anti-inflammatory drugs inhibit a Fyn-dependent pathway coupled to Rac and stress kinase activation in TCR signaling. Blood 105 (2005) 2042-2048
5. Thon V., Wolf H.M., Sasgary M., Litzman J., Samstag A., Hauber I., et al. Defective integration of activating signals derived from the T cell receptor (TCR) and costimulatory molecules in both CD4+ and CD8+ T lymphocytes of common variable immunodeficiency (CVID) patients. Clin Exp Immunol 110 (1997) 174-181
6. Bayry J., Lacroix-Desmazes S., Kazatchkine M.D., Galicier L., Lepelletier Y., Webster D., et al. Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood 104 (2004) 2441-2443
7. Scott-Taylor T.H., Green M.R., Eren E., and Webster A.D. Monocyte derived dendritic cell responses in common variable immunodeficiency. Clin Exp Immunol 138 (2004) 484-490
8. Cunningham-Rundles C., and Radigan L. Deficient IL-12 and dendritic cell function in common variable immune deficiency. Clin Immunol 115 (2005) 147-153
9. Aspalter R.M., Sewell W.A., Dolman K., Farrant J., and Webster A.D. Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia. Clin Exp Immunol 121 (2000) 506-514
10. Serrano D., Becker K., Cunningham-Rundles C., and Mayer L. Characterization of the T cell receptor repertoire in patients with common variable immunodeficiency: oligoclonal expansion of CD8(+) T cells. Clin Immunol 97 (2000) 248-258
11. Paccani S.R., Boncristiano M., Patrussi L., Ulivieri C., Wack A., Valensin S., et al. Defective Vav expression and impaired F-actin reorganization in a subset of patients with common variable immunodeficiency characterized by T-cell defects. Blood 106 (2005) 626-634
12. Grimbacher B., Hutloff A., Schlesier M., Glocker E., Warnatz K., Drager R., et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 4 (2003) 261-268
13. Salzer U., Chapel H.M., Webster A.D., Pan-Hammarstrom Q., Schmitt-Graeff A., Schlesier M., et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 37 (2005) 820-828
14. Castigli E., Wilson S.A., Garibyan L., Rachid R., Bonilla F., Schneider L., et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 37 (2005) 829-834
15. Ohm-Laursen L., Schjebel L., Jacobsen K., Permin H., Svejgaard A., and Barington T. Normal ICOS, ICOSL and AID alleles in Danish patients with common variable immunodeficiency. Scand J Immunol 61 (2005) 566-574
16. Salzer U., Maul-Pavicic A., Cunningham-Rundles C., Urschel S., Belohradsky B.H., Litzman J., et al. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol 113 (2004) 234-240
17. Izquierdo M., Leevers S.J., Marshall C.J., and Cantrell D. p21ras couples the T cell antigen receptor to extracellular signal-regulated kinase 2 in T lymphocytes. J Exp Med 178 (1993) 1199-1208
18. Villalba M., Hernandez J., Deckert M., Tanaka Y., and Altman A. Vav modulation of the Ras/MEK/ERK signaling pathway plays a role in NFAT activation and CD69 up-regulation. Eur J Immunol 30 (2000) 1587-1596
19. Baier-Bitterlich G., Uberall F., Bauer B., Fresser F., Wachter H., Grunicke H., et al. Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol Cell Biol 16 (1996) 1842-1850
20. Coudronniere N., Villalba M., Englund N., and Altman A. NF-kappa B activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta. Proc Natl Acad Sci U S A 97 (2000) 3394-3399
21. Lin X., O'Mahony A., Mu Y., Geleziunas R., and Greene W.C. Protein kinase C-theta participates in NF-kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta. Mol Cell Biol 20 (2000) 2933-2940
22. Grafton G., and Thwaite L. Calcium channels in lymphocytes. Immunology 104 (2001) 119-126
23. Aspalter R.M., Eibl M.M., and Wolf H.M. Regulation of TCR-mediated T cell activation by TNF-RII. J Leukoc Biol 74 (2003) 572-582
24. Banerjee D., Liou H.C., and Sen R. c-Rel-dependent priming of naive T cells by inflammatory cytokines. Immunity 23 (2005) 445-458
25. Beyaert R., and Fiers W. Tumor necrosis factor and lymphotoxin. In: Mire-Sluis A., and Thorpe R. (Eds). Cytokines (1998), Academic Press, San Diego (CA)
26. Kristufek D., Aspalter R.M., Eibl M.M., and Wolf H.M. Characterization of novel Bruton's tyrosine kinase gene mutations in Central European patients with agammaglobulinemia. Mol Immunol 44 (2007) 1639-1643
27. Aspalter R.M., Wolf H.M., and Eibl M.M. Chronic TNF-alpha exposure impairs TCR-signaling via TNF-RII but not TNF-RI. Cell Immunol 237 (2005) 55-67
28. Meller N., Liu Y.C., Collins T.L., Bonnefoy-Berard N., Baier G., Isakov N., et al. Direct interaction between protein kinase C theta (PKC theta) and 14-3-3 tau in T cells: 14-3-3 overexpression results in inhibition of PKC theta translocation and function. Mol Cell Biol 16 (1996) 5782-5791
29. Rijkers G.T., Justement L.B., Griffioen A.W., and Cambier J.C. Improved method for measuring intracellular Ca++ with fluo-3. Cytometry 11 (1990) 923-927
30. D'Ambrosio D., Cantrell D.A., Frati L., Santoni A., and Testi R. Involvement of p21ras activation in T cell CD69 expression. Eur J Immunol 24 (1994) 616-620
31. Risso A., Smilovich D., Capra M.C., Baldissarro I., Yan G., Bargellesi A., et al. CD69 in resting and activated T lymphocytes: its association with a GTP binding protein and biochemical requirements for its expression. J Immunol 146 (1991) 4105-4114
32. Taylor-Fishwick D.A., and Siegel J.N. Raf-1 provides a dominant but not exclusive signal for the induction of CD69 expression on T cells. Eur J Immunol 25 (1995) 3215-3221
33. Church L.D., Goodall J.E., Rider D.A., Bacon P.A., and Young S.P. Persistent TNF-alpha exposure impairs store operated calcium influx in CD4+ T lymphocytes. FEBS Lett 579 (2005) 1539-1544
34. Borovsky Z., Mishan-Eisenberg G., Yaniv E., and Rachmilewitz J. Serial triggering of T cell receptors results in incremental accumulation of signaling intermediates. J Biol Chem 277 (2002) 21529-21536
35. Saloga J., Schwinzer R., Renz H., Terada N., Or R., and Gelfand E.W. Characterization of the progression signal for human T-cell proliferation provided by monoclonal antibodies to the CD3-TCR complex. Clin Immunol Immunopathol 67 (1993) 232-239
36. Tartaglia L.A., Weber R.F., Figari I.S., Reynolds C., Palladino Jr. M.A., and Goeddel D.V. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci U S A 88 (1991) 9292-9296
37. Tartaglia L.A., Goeddel D.V., Reynolds C., Figari I.S., Weber R.F., Fendly B.M., et al. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J Immunol 151 (1993) 4637-4641
38. Cope A.P., Liblau R.S., Yang X.D., Congia M., Laudanna C., Schreiber R.D., et al. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med 185 (1997) 1573-1584
39. Pimentel-Muinos F.X., Mazana J., and Fresno M. Biphasic control of nuclear factor-kappa B activation by the T cell receptor complex: role of tumor necrosis factor alpha. Eur J Immunol 25 (1995) 179-186
40. Hostager B.S., and Bishop G.A. Role of TNF receptor-associated factor 2 in the activation of IgM secretion by CD40 and CD120b. J Immunol 168 (2002) 3318-3322
41. Schwenzer R., Siemienski K., Liptay S., Schubert G., Peters N., Scheurich P., et al. The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-kappaB and c-Jun N-terminal kinase. J Biol Chem 274 (1999) 19368-19374
42. Arron J.R., Pewzner-Jung Y., Walsh M.C., Kobayashi T., and Choi Y. Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling. J Exp Med 196 (2002) 923-934